MACKENZIE BOYER: Open Payments
NPI 1598400129 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 24 payments from 10 companies in 2025. Trend: 2023 $799 · 2024 $563 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $225 |
| PFIZER INC. | 11 | $178 |
| Organon LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $30 |
| Novo Nordisk Inc | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: AIRSUPRA, PREVNAR 20, NURTEC ODT, NEXPLANON, MOUNJARO, Ozempic, ELIQUIS, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
